Skip to main content

Table 4 Fasting plasma lipid concentrations, glucose and insulin AUC after MTT and hepatic TG

From: Increased hypolipidemic benefits of cis-9, trans-11 conjugated linoleic acid in combination with trans-11 vaccenic acid in a rodent model of the metabolic syndrome, the JCR:LA-cp rat

  Dietary groups
  Lean control Obese control Obese CLA Obese VA+CLA
TG (mmol/L) 0.47 ± 0.0c 3.28 ± 0.4a 2.05 ± 0.3*b 1.4 ± 0.1***bc
NEFA (mmol/L) 0.20 ± 0.02c 0.48 ± 0.02ab 0.57 ± 0.03a 0.42 ± 0.05b
TC (mmol/L) 2.26 ± 0.0c 6.18 ± 0.4a 4.22 ± 0.2***b 4.92 ± 0.2**b
LDL-C (mmol/L) 0.97 ± 0.1c 2.28 ± 0.2a 1.56 ± 0.1**b 1.2 ± 0.1***bc
Fasting glucose (mmol/L) 5.94 ± 0.08 6.81 ± 0.4 5.94 ± 0.36 6.75 ± 0.72
Glucose iAUC (mmol/L.h) 45.19 ± 4.5 52.22 ± 7.8 70.25 ± 14.7 42.7 ± 33.05
Fasting insulin (μIU/L) 73.41 ± 27.4b 629.2 ± 165.3a 216 ± 13.6*b 372.8 ± 98.24ab
Insulin AUC (μIU/L.h) 8739 ± 1566 c 40437 ± 4384 a 24548 ± 3465*b 23001 ± 2744*b
Insulin iAUC (μIU/L.h) 4452 ± 1464 11805 ± 7603 11585 ± 3885 4451 ± 3015
Liver TG (mmol/g protein) 2.2 ± 0.3d 21.2 ± 1.0a 16.6 ± 1.1*b 12.1 ± 1.3***c
  1. Plasma lipid and liver TG values are mean ± SEM, n = 8. Insulin AUC is mean ± SEM, n = 4. Means in the same raw with different symbol are significantly different as compared to obese control; *P < 0.05, **P < 0.01, ***P < 0.001. Means in the same raw with different letter are significantly different among control (lean and obese) and obese treated groups (CLA and VA+CLA).